Gold Nanoparticle Therapeutics in Alzheimer's Disease Revolutionizing Diagnosis and Treatment

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.

Dr. Mahesh Narayan is a Professor in the Department of Chemistry and Biochemistry at the University of Texas at El Paso (USA). He earned a B.Sc. in Physics from Bombay University (1991) and a Ph.D. in Biophysics from The Ohio State University (1997). He completed postdoctoral studies at Cornell University (1997–2000) and later served as a Senior Research Associate there (2002–2005). Dr. Narayan has authored and co-authored articles and book chapters in free radical biology, protein structure-function relationships, oxidative folding, protein misfolding, halogen bonding, in silico drug design, the agricultural impact of nanomaterials, and chemical education. His work has been recognized by invitations to speak at over 15 international forums and by coverage in various media outlets. His research focuses on intracellular mechanisms in neurodegenerative disorders, particularly the effects of xenobiotics on amyloid proteins.

Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.